$146.69
2.721.89%
가까이에: Sep 11, 5:00 PM EST
$145.49
1.521.05%
프리마켓: 8:35 AM EST
Benzinga
Benzinga
Benzinga
화요일, 9월 15
Moderna Inc
MRNANASDAQ
Moderna Earnings & Forecasts
Moderna (MRNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Moderna Guidance
Moderna (MRNA)는 7월 31, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $2.14B - $2.14B 범위로 예상했습니다.
이전 가이던스와 비교하여 Moderna는 매출 전망치를 이전 범위인 유지됨에서 $2.14B - $2.14B로 상향 조정했습니다.
Moderna은 13과 11월 2, 2023 사이에 7월 31, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 2 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.07 | $-3.71 | $-2.60 | $-2.17 |
| Actual | $-1.97 | $-1.18 | $-2.11 | $-0.51 |
| Surprise | +4.83% | +68.2% | +18.9% | +76.5% |
| Revenue | ||||
| Estimate | $104.4M | $233.8M | $638.9M | $866.0M |
| Actual | $145.0M | $389.0M | $678.0M | $1.02B |
| Surprise | +38.9% | +66.4% | +6.12% | +17.3% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.25 | $-1.75 | $-2.10 | $-2.15 |
| Revenue | ||||
| Consensus | $893.7M | $669.5M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved